LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) insider Danish J. Qureshi sold 12,965 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $5.93, for a total transaction of $76,882.45. Following the transaction, the insider now owns 4,911,050 shares in the company, valued at approximately $29,122,526.50. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
LifeStance Health Group Stock Performance
Shares of NASDAQ LFST opened at $5.71 on Friday. The business’s 50 day moving average price is $6.51 and its 200 day moving average price is $6.54. LifeStance Health Group, Inc. has a 52 week low of $4.74 and a 52 week high of $9.59. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.20.
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03). The company had revenue of $280.60 million during the quarter, compared to analyst estimates of $263.14 million. LifeStance Health Group had a negative net margin of 17.64% and a negative return on equity of 12.66%. On average, equities analysts predict that LifeStance Health Group, Inc. will post -0.3 EPS for the current fiscal year.
Institutional Trading of LifeStance Health Group
Wall Street Analyst Weigh In
LFST has been the topic of a number of recent analyst reports. Jefferies Financial Group raised their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Barclays raised their target price on shares of LifeStance Health Group from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Thursday, February 29th. Finally, The Goldman Sachs Group raised their price target on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $8.60.
View Our Latest Analysis on LifeStance Health Group
LifeStance Health Group Company Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
- Five stocks we like better than LifeStance Health Group
- What is a buyback in stocks? A comprehensive guide for investors
- MarketBeat Week in Review – 4/15 – 4/19
- Investing In Preferred Stock vs. Common Stock
- Comprehensive Analysis of PayPal Stock
- Dividend Payout Ratio Calculator
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.